The landscape of dementia diagnosis has evolved substantially with the advent of advanced biomarkers, such as amyloid PET scans, tau imaging, and blood-centered assessments that can detect Alzheimer's pathology decades ahead of signs arise. When these technological improvements symbolize remarkable development in knowing neurodegenerative illnesses, they may have not diminished https://ericw863rbk2.wikigop.com/user